Supplementary therapy in canine atopic dermatitis

2019 ◽  
Vol 24 (8) ◽  
pp. 400-407
Author(s):  
Sue Paterson
Keyword(s):  
Fatty Acids ◽  
Atopic Dermatitis ◽  
Specific Immunotherapy ◽  
Essential Fatty Acids ◽  
Topical Therapy ◽  
Allergen Specific Immunotherapy ◽  
Canine Atopic Dermatitis ◽  
Adequate Control ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Therapy for canine atopic dermatitis can be described as foundation or supplementary. Foundation therapy, which refers to allergen-specific immunotherapy, ciclosporin, glucocorticoids, lokivetmab and oclacitinib, is needed in all but the mildest of cases of canine atopic dermatitis. Supplementary therapies include drugs such as antihistamines, essential fatty acids, topical therapy and other systemic anti-inflammatory drugs. While it is uncommon for any of these supplementary drugs to provide adequate control of many cases of canine atopic dermatitis, they can reduce the frequency of relapse and reduce the amount of foundation therapy that is required when used in combination with them.

Foundation therapy in canine atopic dermatitis

2019 ◽  
Vol 24 (7) ◽  
pp. 347-352
Author(s):  
Sue Paterson
Keyword(s):  
Fatty Acids ◽  
Atopic Dermatitis ◽  
Strong Evidence ◽  
Specific Immunotherapy ◽  
Essential Fatty Acids ◽  
Evidence Base ◽  
Allergen Specific Immunotherapy ◽  
Canine Atopic Dermatitis ◽  
Topical Emollient ◽  
Risk Of Relapse

Therapy in canine atopic dermatitis should be multimodal and should be individualised for each patient. Therapies can be described as foundation or supplementary. In all but the mildest cases, dogs require a foundation therapy for the control of their atopic dermatitis. These include allergen-specific immunotherapy, ciclosporin, glucocorticoids, lokivetmab or oclacitinib. All of these five therapeutic options have a strong evidence base to recommend their use in canine atopic dermatitis. Supplementary therapies, which include drugs such as antihistamines, essential fatty acids, topical emollient and antiseptics, help in treatment to improve barrier function and correct skin biome dysbiosis, but can rarely control canine atopic dermatitis in isolation. When combined with foundation therapy they can reduce the risk of relapse and the level of foundation therapy that is required. https://doi.org/10.12968/coan.2019.0020

Canine atopic dermatitis — the veterinary ‘eczema’ nurse

2019 ◽  
Vol 10 (6) ◽  
pp. 296-303
Author(s):  
Sue Paterson
Keyword(s):  
Quality Of Life ◽  
Specific Immunotherapy ◽  
Essential Fatty Acids ◽  
Topical Therapy ◽  
Human Medicine ◽  
Allergen Specific Immunotherapy ◽  
Veterinary Surgeons ◽  
Allergic Skin ◽  
Specialist Nurses

In human medicine many NHS hospitals employ ‘eczema specialist’ nurses. These are nurses with additional training that help individuals diagnosed with eczema to manage their own disease and can provide them with the information and support to improve their quality of life. Veterinary nurses as part of a Vet-led Team also have the opportunity to help their clients in a similar way, by advising owners on the best way to manage their allergic pets. In order to provide that support nurses need a thorough grounding in many of the supplementary therapies that can be prescribed by veterinary surgeons as part of a multi-modal approach to allergic skin disease. Supplementary drugs that can be added into a treatment regimen with foundation drugs such as allergen specific immunotherapy, ciclosporine, glucocorticoids, lokivetmab and oclacitinib include drugs such as antihistamines, essential fatty acids and topical therapy in the form of moisturisers.

Sign in / Sign up

Export Citation Format

Share Document